Low‐molecular‐weight heparin (LMWH) is widely used in the prevention and treatment of venous thromboembolism (VTE), and anti‐Xa assay is the gold standard for monitoring LMWH. However, it is still controversial whether monitoring is necessary for patients receiving LMWH therapy. Therefore, we conducted a meta‐analysis to explore the effect of anti‐Xa monitoring on the safety and efficacy of LMWH anticoagulant therapy.

中文翻译：

---

抗Xa监测对低分子量肝素抗凝治疗的安全性和有效性的影响：系统评价和荟萃分析。

低分子量肝素（LMWH）被广泛用于预防和治疗静脉血栓栓塞（VTE），抗Xa分析是监测LMWH的金标准。但是，对于接受LMWH治疗的患者是否需要进行监测仍存在争议。因此，我们进行了荟萃分析，以探讨抗Xa监测对LMWH抗凝治疗的安全性和有效性的影响。